Back to results
US 11,883,395 B2Granted
Method of treating severe acute respiratory syndrome (SARS) virus infection by administering a protein disulfide isomerase (PDI) inhibitor
AssigneeUniversity of Vermont and State Agricultural College
InventorsVikas Anathy, Nicolas Chamberlain, Amit Kumar
Life of this patent
Estimating the term…
Abstract
Compositions and methods involving protein disulfide isomerase (PDI) inhibitors, such as protein disulfide isomerase A3 (PDIA3) inhibitory compounds, for human coronavirus, such as severe acute respiratory syndrome (SARS) virus (e.g., SARS-CoV-2), therapies are disclosed herein.
Claims19
A method of treating a severe acute respiratory syndrome (SARS) virus infection, the method comprising administering to a subject in need thereof, a composition comprising a protein disulfide isomerase (PDI) inhibitor and a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.